1
|
Georgin-Lavialle S, Savey L, Cuisset L, Boursier G, Boffa JJ, Delplanque M, Bourguiba R, Monfort JB, Touitou I, Grateau G, Kone-Paut I, Hentgen V. French protocol for the diagnosis and management of familial Mediterranean fever. Rev Med Interne 2023; 44:602-616. [PMID: 37903671 DOI: 10.1016/j.revmed.2023.10.441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2023] [Accepted: 10/08/2023] [Indexed: 11/01/2023]
Abstract
Familial Mediterranean fever is the most common monogenic auto-inflammatory disease in the world. It mainly affects people originating from the Mediterranean region. The mutated gene is MEFV, which codes for pyrin. Transmission is autosomal recessive. Patients present with recurrent attacks of fever since childhood associated with abdominal and/or thoracic pain lasting an average of 2-3days and a biological inflammatory syndrome. Other symptoms include arthralgia or arthritis in large joints such as the knees and ankles, myalgia in the lower limbs and pseudo-erysipelas in the ankles. The most serious complication is inflammatory amyloidosis, which can lead to kidney failure. Treatment is based on colchicine, which helps to prevent flares and the onset of renal amyloidosis. This paper proposes national guidelines for the diagnosis, management and follow-up of familial Mediterranean fever in France, where we estimate there are between 5000 and 10,000 patients with the disease at all stages of life. The diagnosis is suspected on the basis of clinical and anamnestic factors and confirmed by genetic analysis. These guidelines also suggest a "treat-to-target" approach to disease management, particularly in case of suspected colchicine resistance - a very rare situation that should remain a diagnosis of elimination, especially after colchicine compliance has been verified. Two special situations are also addressed in these guidelines: kidney failure and pregnancy.
Collapse
Affiliation(s)
- S Georgin-Lavialle
- Internal Medicine, Sorbonne University, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France.
| | - L Savey
- Internal Medicine, Sorbonne University, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - L Cuisset
- Genetics, Cochin Hospital, Paris, France
| | - G Boursier
- Genetics, Montpellier University, Montpellier, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - J-J Boffa
- Nephrology, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - M Delplanque
- Internal Medicine, Sorbonne University, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - R Bourguiba
- Internal Medicine, Sorbonne University, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - J-B Monfort
- Dermatology, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - I Touitou
- Genetics, Montpellier University, Montpellier, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - G Grateau
- Internal Medicine, Sorbonne University, Tenon Hospital, Paris, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - I Kone-Paut
- Rhumatopediatry, Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| | - V Hentgen
- Paediatric Rheumatology, Versailles Hospital, Versailles, France; CEREMAIA: French National Reference Center for Auto-inflammatory Diseases and AA Amyloidosis, Paris, France
| |
Collapse
|
2
|
Georgin-Lavialle S, Savey L, Buob D, Bastard JP, Fellahi S, Karras A, Boffa JJ, Grateau G, Audard V, Bridoux F, Damade R, Deshayes S, Giurgea I, Granel B, Hachulla E, Hot A, Jaccard A, Knebelmann B, Marciano S, Pelcot F, Sarrabay G, Boursier G, Sellam J, Terre A, Bourguiba R. French practical guidelines for the diagnosis and management of AA amyloidosis. Rev Med Interne 2023; 44:62-71. [PMID: 36759076 DOI: 10.1016/j.revmed.2022.12.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Accepted: 12/11/2022] [Indexed: 01/25/2023]
Abstract
AA amyloidosis is secondary to the deposit of excess insoluble Serum Amyloid A (SAA) protein fibrils. AA amyloidosis complicates chronic inflammatory diseases, especially chronic inflammatory rheumatisms such as rheumatoid arthritis and spondyloarthritis; chronic infections such as tuberculosis, bronchectasia, chronic inflammatory bowel diseases such as Crohn's disease; and auto-inflammatory diseases including familial Mediterranean fever. This work consists of the French guidelines for the diagnosis workup and treatment of AA amyloidosis. We estimate in France between 500 and 700 cases in the whole French population, affecting both men and women. The most frequent organ impaired is kidney which usually manifests by oedemas of the lower extremities, proteinuria, and/or renal failure. Patients are usually tired and can display digestive features anf thyroid goiter. The diagnosis of AA amyloidosis is based on detection of amyloid deposits on a biopsy using Congo Red staining with a characteristic green birefringence in polarized light. Immunohistochemical analysis with an antibody directed against Serum Amyloid A protein is essential to confirm the diagnosis of AA amyloidosis. Peripheral inflammatory biomarkers can be measured such as C Reactive protein and SAA. We propose an algorithm to guide the etiological diagnosis of AA amyloidosis. The treatement relies on the etiologic treatment of the undelying chronic inflammatory disease to decrease and/or normalize Serum Amyloid A protein concentration in order to stabilize amyloidosis. In case of renal failure, dialysis or even a kidney transplant can be porposed. Nowadays, there is currently no specific treatment for AA amyloidosis deposits which constitutes a therapeutic challenge for the future.
Collapse
Affiliation(s)
- S Georgin-Lavialle
- Sorbonne University, Internal medicine department, Tenon hospital, National reference center for autoinflamamtory diseases and AA amylodiosis (CEREMAIA), 4 rue de la Chine, 75020 Paris, France.
| | - L Savey
- Sorbonne University, Internal medicine department, Tenon hospital, National reference center for autoinflamamtory diseases and AA amylodiosis (CEREMAIA), 4 rue de la Chine, 75020 Paris, France
| | - D Buob
- Sorbonne University, department of pathology, Tenon hospital, Paris, France
| | - J-P Bastard
- Biochemistry department, Henri-Mondor hospital, Créteil, France
| | - S Fellahi
- Sorbonne University, Nephrology department, Tenon hospital, Paris, France
| | - A Karras
- Paris centre university, Nephrology department, Georges Pompidou European hospital, Paris, France
| | - J-J Boffa
- Sorbonne University, Nephrology department, Tenon hospital, Paris, France
| | - G Grateau
- Sorbonne University, Internal medicine department, Tenon hospital, National reference center for autoinflamamtory diseases and AA amylodiosis (CEREMAIA), 4 rue de la Chine, 75020 Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Alhenc-Gelas M, Lefevre G, Bachmeyer C, M'Bappe P, Ouahabi S, Grateau G, Letavernier E, Steichen O. Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department. Rev Med Interne 2021; 43:206-211. [PMID: 34953621 DOI: 10.1016/j.revmed.2021.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 11/13/2021] [Accepted: 11/28/2021] [Indexed: 10/19/2022]
Abstract
INTRODUCTION Hypo- and hypercalcemia are common and some causes require urgent diagnosis and treatment. Measurement of ionized calcium is the reference test to diagnose calcium disorders but total calcium adjusted for protein or albumin concentration is more often used. METHODS Patients hospitalised in a general internal medicine department from September 2013 to December 2015 who had a total plasma calcium concentration and a serum albumin or protein concentration measured within 24h of a ionized calcium blood measurement were included. Total calcium was adjusted for protein or albumin concentration using widely used formulas and compared to ionized calcium as the gold standard. RESULTS Among 210 included patients, 46 (22%) had hypocalcemia, 124 (59%) normocalcemia and 40 (19%) hypercalcemia according to ionized calcium concentration. Total calcium had 50% sensitivity and 95% specificity to diagnose hypocalcemia and a 93% sensitivity and 89% specificity to diagnose hypercalcemia. Adjusting total calcium for protein or albumin concentrations did not increase and sometimes decreased diagnostic accuracy. CONCLUSION Total calcium, with or without albumin/protein adjustment, is poorly sensitive to screen for hypocalcemia. Unadjusted total calcium is as sensitive as protein- or albumin-adjusted total calcium to screen for hypercalcemia. These data argue against the use of albumin- or protein-adjusted calcium. Ionized calcium measurement should be performed to confirm dyscalcemia in patients with abnormal total calcium concentration and to rule out hypocalcemia in patients with total calcium concentration in the lower range of normal values.
Collapse
Affiliation(s)
- M Alhenc-Gelas
- Service de médecine interne, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - G Lefevre
- Laboratoire de biochimie, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - C Bachmeyer
- Service de médecine interne, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - P M'Bappe
- Service de médecine interne, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - S Ouahabi
- Laboratoire de biochimie, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - G Grateau
- Service de médecine interne, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - E Letavernier
- Explorations fonctionnelles rénales, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France
| | - O Steichen
- Service de médecine interne, Assistance Publique-Hôpitaux de Paris (AP-HP), hôpital Tenon, 75020 Paris, France; Sorbonne université, Inserm, Institut Pierre-Louise d'épidémiologie et de santé publique (IPLESP, UMR-S1136), 75006 Paris, France.
| |
Collapse
|
4
|
Delplanque M, Ducharme-Bénard S, Moguelet P, Chasset F, Grateau G, Georgin-Lavialle S, Bachmeyer C. Is neutrophilic dermatosis a manifestation of familial Mediterranean fever? Scand J Rheumatol 2021; 51:42-49. [PMID: 34159892 DOI: 10.1080/03009742.2021.1904588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Objectives: Familial Mediterranean fever (FMF) is the most frequent monogenic autoinflammatory disease. It is associated with MEFV mutations. Its main features are recurrent episodes of fever and serositis. Patients can display dermatological manifestations such as erysipelas-like erythema, generally considered as a neutrophilic dermatosis (ND). It has been suggested that FMF can be associated with other types of ND. Our aim was to perform a systematic review of the literature to assess the link between ND and FMF.Method: A systematic review of the literature was performed using MEDLINE from 1946 to 2018. Three independent investigators identified reports of non-erysipelas-like erythema neutrophilic dermatosis (NEND) associated with FMF, selected the criteria to establish the diagnosis of FMF and ND, and evaluated the link between the two conditions. FMF-associated NEND was supported by confirmation of both diagnoses and exclusion of other causes of ND.Results: Eighteen articles were selected. Nine articles reported FMF patients with the following NEND: neutrophilic panniculitis (n = 4), Sweet syndrome (n = 6), and pyoderma gangrenosum (n = 1). None of these cases was supported by histological confirmation, fulfilled diagnostic criteria for definitive or probable FMF, or confirmed the exclusion of all the most frequent diseases associated with NEND. As a result, there is insufficient evidence to support a potential relationship between NEND and FMF.Conclusions: The association between FMF and NEND remains unclear. In FMF patients with NEND, every differential diagnosis and alternative cause of NEND should be excluded before drawing any conclusions about a potential causal relationship.
Collapse
Affiliation(s)
- M Delplanque
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - S Ducharme-Bénard
- Internal Medicine Department, Sacré-Coeur Hospital, Montreal, Canada
| | - P Moguelet
- Anatomopathology Department, Tenon Hospital, Paris, France
| | - F Chasset
- Dermatology Department, Tenon Hospital, Paris, France
| | - G Grateau
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - S Georgin-Lavialle
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - C Bachmeyer
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| |
Collapse
|
5
|
Bourguiba R, Delplanque M, Caroline V, Savey L, Grateau G, Hentgen V, Georgin-Lavialle S. La fièvre méditerranéenne familiale est-elle uns situation à risque de développer une forme grave d’infection par la COVID19 ? Résultat d’une étude rétrospective sur 627 patients en période et zone endémique en France. Rev Med Interne 2021. [PMCID: PMC8192023 DOI: 10.1016/j.revmed.2021.03.266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Introduction La nouvelle pandémie mondiale (COVID19) causée par le coronavirus 2 du syndrome respiratoire aigu sévère (SRAS-CoV-2) est responsable de nombreux décès dans le monde entier au cours des derniers mois. Au cours des formes graves, il a été noté une réponse inflammatoire exagérée connue sous le nom de “orage cytokinique”. Ceci a soulevé la question de la sensibilité et de la gravité de l’infection par le SRAS-CoV2 chez les patients présentant une hyperactivation génétique de l’immunité innée tels que la fièvre méditerranéenne familiale (FMF). En outre, les patients avec FMF prennent de la colchicine au long cours, médicament qui a été testé chez des patients infectés par le SRAS-CoV2 avec des résultats contradictoires [1]. Patients et méthodes Étude menée sur l’infection par le SRAS-CoV2 chez les patients atteints de FMF suivis dans 2 sites du centre de référence national des maladies autoinflammatoires en région parisienne et inclus dans la JIR cohorte, une base de données européenne multicentrique. Les patients adultes et pédiatriques inclus répondaient aux critères internationaux de FMF et avaient un diagnostic génétique confirmé. Résultats Les patients identifiés (n = 627) ont été invités à répondre à un bref questionnaire soit en consultation, soit par téléphone, soit par courrier électronique sur une possible infection par le SARS-CoV2 pendant la période de mars à juin 2020 ; 342 patients ont répondu à l’enquête. Le diagnostic était retenu si le patient présentait des symptômes cliniques avec PCR ou sérologie positive ou scanner thoracique typique. Au total, 27 patients FMF (7,8 % des répondants ; sexe ratio 1/1) ont contracté le virus. Tous les 27 patients FMF-COVID+ sauf un prenaient de la colchicine quotidiennement depuis une période médiane de 23 ans, la dose moyenne de colchicine était de 1 mg/jour. Quatre recevaient en plus un inhibiteur de l’IL-1. Parmi les 27 patients FMF-COVID+, sept symptomatiques ont été hospitalisés (25 %) et six ont eu besoin d’oxygène ; trois (11 %) ont développé un syndrome de détresse respiratoire aiguë nécessitant des soins intensifs pour une ventilation mécanique et une hémodialyse. Deux patients sont décédés (7 %) mais présentaient respectivement 3 et 4 comorbidités pour une infection grave par le SRAS-CoV2 ; le troisième patient, âgé de 40 ans, souffrait d’hypertension et d’obésité. Les patients âgés de plus de 65 ans représentaient 17 % de l’ensemble de la cohorte FMF-COVID + ; 75 % ont été hospitalisés et ont eu besoin d’oxygène ; l’un d’eux est décédé. Trois patients FMF-COVID + avaient une amylose AA : 2 ont été hospitalisés et un est décédé. Aucun traitement anti-viral supplémentaire n’a été administré. Les 5 survivants après hospitalisation sont rentrés chez eux. Aucun d’entre eux n’a présenté de signes cliniques de crise de FMF lors de l’infection par le SRAS-CoV2. Discussion Le profil des patients FMF atteints d’une forme grave ou potentiellement mortelle par le SRAS-CoV2 était le même que celui de la population générale. Ainsi, seuls les patients FMF présentant des facteurs de risque connus (tels que âge avancé, maladie rénale chronique, hypertension, maladie vasculaire, obésité et dysfonctionnement pulmonaire) ont développé une infection grave par le SARS-CoV2 [2]. Cette étude n’est pas en faveur d’un surrisque en soi de développer une infection sévère à SRAS-CoV2 en présence d’une maladie autoinflammatoire monogénique touchant un inflammasome. Aucune conclusion formelle ne peut être tirée sur l’effet préventif de la colchicinothérapie au long cours, bien que ce travail rétrospectif porte sur une large cohorte de patients traités par colchicine depuis plusieurs années. Il est difficile de conclure à l’efficacité du traitement par inhibiteur d’IL1 vis-à-vis l’infection par le SRAS-CoV-2 chez les patients FMF, mais 50 % des patients traités au long cours sont décédés mais avaient plusieurs comorbidités ; et des publications récentes semblent plaider en faveur de l’efficacité de l’anakinra dans l’infection grave par le SRAS-CoV-2 [3]. Conclusion La FMF ne semble pas constituer un facteur de risque de développer une forme sévère d’infection par SARS-CoV2 chez les patients traités au long cours par de la colchicine quotidienne, par rapport à la population générale.
Collapse
|
6
|
Bourguiba R, Savey L, Dumont A, Ardois S, Vergneault H, Giurgea I, Amselem S, Grateau G, Georgin-Lavialle S. Errance diagnostique dans la fièvre méditerranéenne familiale : à propos de 85 cas dans une cohorte de 560 patients adultes. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Deshayes S, Bourguiba R, Haymann JP, Lea.Savey@aphp.Fr>; LSF, Aouba A, Grateau G, Georgin-Lavialle S. POS1343 ABNORMAL ELECTROCHEMICAL SKIN CONDUCTANCE VALUES IN PATIENTS WITH AA AMYLOIDOSIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Clinical manifestations are scarce in AA amyloidosis (AAA) and, contrary to other types of amyloidosis, involvement of the peripheral nervous system was rarely reported in AAA. However, the usual absence of hypertension despite chronic renal failure and the digestive involvement may be secondary to dysautonomia, but the autonomic nervous system has rarely been studied in AAA (1). Measure of the electrochemical skin conductance (ESC) is a simple and reproducible method to evaluate the function of eccrine sweat glands, which are innervated by small non-myelinated C fibers, and patients with AL and hereditary transthyretin amyloidoses show decreased ESC values (2,3).Objectives:To evaluate ESC values by Sudoscan in patients with AAA.Methods:Patients diagnosed as having AAA based on positive immunohistochemistry with an anti-serum amyloid A antibody followed at the national reference center for AAA in Tenon Hospital between July, 2017 and September, 2020, were routinely assessed for ESC with FDA approved Sudoscan (Impeto Medical, Paris, France). An ESC value above 60 microSiemens (µS) or 70 µS were considered normal for hands or feet, respectively. Categorical variables are reported as percentages and continuous variables are expressed as means±standard deviation. Correlations between age, body mass index (BMI), hemoglobin levels, C-reactive protein levels, estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation (defined as 0 for dialysis patients) and ESC values were calculated using the nonparametric Spearman test. GraphPad Prism Version 7 software (GraphPad Software, San Diego, California, USA) was used for statistical analyses. A p-value <0.05 was considered as statistically significant.Results:Overall, 32 patients (16 women) were included, with a mean age of 57.4±13.6 years and a mean BMI of 25.2±6.8 kg/m2. Six (19%) had diabetes mellitus, and 5 (16%) had a kidney transplantation. The main causes of AAA were: monogenic autoinflammatory diseases (n=11, 34%, including 9 patients with familial Mediterranean fever), chronic and/or recurrent infections (n=5, 16%), obesity (n=3, 9%) and undefined (n=3, 9%). The mean hands’ ESC values was normal at 65.5±21.1 µS, although 8 (25%) patients had ESC values below 60 µS, including 2 diabetic patients. In contrast, the mean feet’s ESC values was abnormal at 62.7±23.7 µS, including half of the patients with ESC values below 70 µS (2 diabetic patients). Eight patients had abnormal ESC values only for feet, and 1 had abnormal values only for hands. Apart from a significant correlation between feet and hands’ ESC values (p<0.0001), only the estimated glomerular filtration rate was significantly associated with hands’ ESC values (p<0.01).Conclusion:To our knowledge, this is the first study to assess ESC in AAA. Feet’s ESC values were moderately impaired in half of the patients with AAA. Therefore, this study reinforces the previously reported alterations in the autonomic nervous system in patients with AAA that should probably be searched for in these patients. In addition, the identification of an alteration of the ESC values cannot allow to distinguish the type of amyloidosis.References:[1]Nussinovitch U, Volovitz B, Nussinovitch M, Lidar M, Feld O, Nussinovitch N, et al. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever. Amyloid 2011;18:206–10.[2]Montcuquet A, Duchesne M, Roussellet O, Jaccard A, Magy L. Electrochemical skin conductance values suggest frequent subclinical autonomic involvement in patients with AL amyloidosis. Amyloid 2020;27:215–6.[3]Fortanier E, Delmont E, Verschueren A, Attarian S. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2020;131:1129–33.Disclosure of Interests:None declared
Collapse
|
8
|
Deshayes S, Bazille C, Giurgea I, Martin Silva N, Ollivier I, Dumont A, Trenec M, Elhani I, Amselem S, De Boysson H, Grateau G, Georgin-Lavialle S, Aouba A. Hépatopathie chronique dans le spectre clinique de l’haplo-insuffisance en A20 (HA20) : description clinique et histopathologique à partir d’une famille française porteuse d’une nouvelle mutation de TNFAIP3. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Fayand A, Chasset F, David B, Grateau G, Touitou I, Guilaine B, Georgin-Lavialle S. La place de l’interniste dans le diagnostic du déficit en adénosine déaminase 2 à l’âge adulte : à propos de 233 cas dont 12 patients français. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Bourguiba R, Savey L, Aouba A, Deshayes S, Fain O, Martin-Silva N, Hentgen V, Desdoits A, Grateau G, Giurgea I, Georgin-Lavialle S. [Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin]. Rev Med Interne 2020; 42:459-464. [PMID: 33131906 DOI: 10.1016/j.revmed.2020.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/23/2020] [Accepted: 08/30/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Tumor Necrosis Factor Type 1 Receptor Associated Periodic Syndrome (TRAPS) is a rare autosomal dominant autosomal autoinflammatory disease associated with mutations in the TNF type 1 receptor gene (TNFRSF1A). It is characterized by relatively long recurrent febrile seizures with an average duration of 7 days accompanied by arthralgia, myalgia, and usually a rash. In a patient of Mediterranean origin with recurrent fever, familial Mediterranean fever is the first diagnosis to be suspected by argument of frequency. METHODS A retrospective observational study was conducted on patients from Mediterranean origin followed for TRAPS and included in the "Juvenile Inflammatory Rheumatism" (JIR) observational cohort in the national French autoinflammatory center. The age of onset of symptoms, age of diagnosis, number of years of wandering and treatments received were collected for each index case. RESULTS Nine patients from 6 families of Mediterranean origin were included. A molecular diagnosis confirmed TRAPS in all patients. The median age at diagnosis was 26 years, the mean number of years of wandering was 17 years. The diagnosis of FMF was made first in all patients. AA amyloidosis revealed TRAPS in 2 patients. Colchicine was started without any efficacy in all cases. Five patients were treated with interleukin-1 inhibitory biotherapy with 100% efficacy. CONCLUSION In a patient of Mediterranean origin presenting with recurrent febrile abdominal pain of AA amyloidosis, the first diagnosis to be suspected is FMF. Long relapses, dominant transmission, a non-Mediterranean relative, and the ineffectiveness of colchicine should evoke TRAPS.
Collapse
Affiliation(s)
- R Bourguiba
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Sorbonne université, hôpital Tenon, AP-HP, 20, rue de la Chine, 75020 Paris, France
| | - L Savey
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Sorbonne université, hôpital Tenon, AP-HP, 20, rue de la Chine, 75020 Paris, France
| | - A Aouba
- Service de médecine interne, Unicaen, CHU de Caen Normandie, Normandie université, 14000 Caen, France
| | - S Deshayes
- Service de médecine interne, Unicaen, CHU de Caen Normandie, Normandie université, 14000 Caen, France
| | - O Fain
- Service de médecine interne, Sorbonne université, hôpital Saint-Antoine, AP-HP, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France
| | - N Martin-Silva
- Service de médecine interne, Unicaen, CHU de Caen Normandie, Normandie université, 14000 Caen, France
| | - V Hentgen
- Service de pédiatrie générale, centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), hôpital André-Mignot, Versailles, France
| | - A Desdoits
- Service de pédiatrie générale, CHU de Caen Normandie, 14000 Caen, France
| | - G Grateau
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Sorbonne université, hôpital Tenon, AP-HP, 20, rue de la Chine, 75020 Paris, France
| | - I Giurgea
- Laboratoire de génétique médicale, Inserm U933, Sorbonne université, hôpital Trousseau, Paris, France
| | - S Georgin-Lavialle
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Sorbonne université, hôpital Tenon, AP-HP, 20, rue de la Chine, 75020 Paris, France.
| |
Collapse
|
11
|
Bourguiba R, Savey L, Aouba A, Martin-Silva N, Fain O, Giurgea I, Grateau G, Georgin-Lavialle S. Le syndrome de fièvre prolongée associée aux mutations du gène du récepteur au TNF de type 1 : un diagnostic différentiel de la fièvre méditerranéenne familiale à ne pas méconnaître chez les patients méditerranéens. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Capron J, Grateau G, Steichen O. The missing link between familial Mediterranean fever and recurrent aseptic meningitis. Pediatr Neonatol 2019; 60:350. [PMID: 30954407 DOI: 10.1016/j.pedneo.2019.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2016] [Accepted: 03/07/2019] [Indexed: 11/17/2022] Open
Affiliation(s)
- J Capron
- Assistance Publique - Hôpitaux de Paris, Hôpital Saint Antoine, Service de neurologie, F-75012, Paris, France.
| | - G Grateau
- Assistance Publique - Hôpitaux de Paris, Hôpital Tenon, Service de médecine interne, F-75020, Paris, France
| | - O Steichen
- Assistance Publique - Hôpitaux de Paris, Hôpital Tenon, Service de médecine interne, F-75020, Paris, France
| |
Collapse
|
13
|
Delplanque M, Galicier L, Oziol E, Boutboul D, Boffa J, Cez A, Buob D, Grateau G, Georgin-Lavialle S. Amylose AA secondaires aux déficits immunitaires : à propos de 40 cas dont 3 nouveaux cas français. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Pourcher V, Breillat P, Deshayes S, Michel P, Angelard B, Arnulf B, Talbot A, Buob D, Grateau G, Georgin-Lavialle S. Amylose et VIH : étude française multicentrique et revue de la littérature. Med Mal Infect 2019. [DOI: 10.1016/j.medmal.2019.04.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
Deshayes S, Fellahi S, Bastard J, Launay J, Callebert J, Fraisse T, Buob D, Boffa J, Aouba A, Grateau G, Sokol H, Georgin-Lavialle S. La fièvre méditerranéenne familiale et l’amylose AA s’accompagnent d’une dysbiose : étude transversale sur 60 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Rouet A, Deshayes S, Savey L, Grateau G, Georgin-Lavialle S. Qualité de vie des patients âgés de plus de 65 ans atteints de fièvre méditerranéenne familiale : résultats d’une étude comparative transversale sur 52 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Allali S, Lionnet F, Mattioni S, Bachmeyer C, Arlet J, Brousse V, De Montalembert M, Chalumeau M, Grateau G, Hermine O, Launay J, Georgin Lavialle S. Augmentation des taux plasmatiques d’histamine chez les patients atteints de drépanocytose. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
18
|
Savey L, Bachmeyer C, Fain O, Loi V, Fayand A, Chauchard M, Louvrier C, Giurgea I, Amselem S, Grateau G, Georgin Lavialle S. Péritonite encapsulée chronique et mésothéliome péritonéal associés à la fièvre méditerranéenne familiale : à propos de 20 cas. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Alhenc-Gelas M, Ouahabi S, Bachmeyer C, Bappe P, Grateau G, Lefevre G, Letavernier E, Steichen O. Calcémie totale et calcémie corrigée par l’albumine ou les protéines totales : valeur diagnostique chez les patients hospitalisés en médecine interne. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
20
|
Breillat P, Georgin Lavialle S, Deshayes S, Michel P, Molina J, Buob D, Fabiani B, Ballester M, Angelard B, Arnulf B, Talbot A, Grateau G. Amyloses associées à l’infection par le VIH : à propos de 23 cas dont 3 français et 20 issus de la littérature. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
21
|
Galland J, Georgin Lavialle S, Deshayes S, Karras A, Buob D, Boffa J, Grateau G. Diagnostic d’amylose AA chez les sujets seniors : étude rétrospective de 25 patients dans un centre de référence. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
22
|
Savey L, Stankovic K, Avellino V, Grateau G, Georgin Lavialle S. Fertilité chez les patients atteints de fièvre méditerranéenne familiale (FMF) : étude au sein d’une population de 331 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
23
|
Georgin Lavialle S, Stankovic K, Avellino V, Quartier P, Bader-Meunier B, Kone-Paut I, Melki I, Belot A, Grateau G, Hentgen V. La transition de la pédiatrie à l’âge adulte dans les maladies auto-inflammatoires : l’expérience d’un centre de référence adulte sur 72 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Terre A, Talbot A, Picque J, Hanslik T, Mahevas M, Boutboul D, Grateau G, Georgin Lavialle S. Le syndrome périodique fébrile associé à des arthralgies et une gammapathie monoclonale : un nouveau syndrome auto-inflammatoire ? Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Rodrigues F, Hentgen V, Bachmeyer C, Kone-Paut I, Belot A, Grateau G, Sarrabay G, Georgin Lavialle S. Les maladies auto-inflammatoires associées aux mutations de NLRC4 : revue systématique de la littérature. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
26
|
Grateau G. Les maladies auto-inflammatoires. Rev Med Interne 2018; 39:211-213. [DOI: 10.1016/j.revmed.2016.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2016] [Accepted: 12/29/2016] [Indexed: 11/28/2022]
|
27
|
Georgin-Lavialle S, Hentgen V, Stankovic Stojanovic K, Bachmeyer C, Rodrigues F, Savey L, Abbara S, Conan PL, Fraisse T, Delplanque M, Rouet A, Sbeih N, Koné-Paut I, Grateau G. [Familial Mediterranean fever]. Rev Med Interne 2018. [PMID: 29526329 DOI: 10.1016/j.revmed.2018.02.005] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Familial Mediterranean Fever (FMF) is the most frequent monogenic auto-inflammatory disease. FMF is an autosomal recessive disease, which affects populations from Mediterranean origin and is associated with MEFV gene mutations encoding for the protein pyrin. Pyrin activation enhances the secretion of interleukin 1 by myelo-monocytic cells. Main features of the disease are acute attacks of serositis mainly located on the abdomen, less frequently on chest and joints, accompanied by fever and biological inflammatory markers elevation. Usually attacks last 1 to 3 days and spontaneously stop. A daily oral colchicine intake of 1 to 2mg/day is able to prevent attack's occurrence, frequency, intensity and duration among most patients. Colchicine is also able to prevent the development of inflammatory amyloidosis, the most severe complication of FMF. This state of the art article will focus on the diagnosis of FMF, the treatment and an update on the pathophysiology including the recent described dominant form of MEFV-associated new auto-inflammatory diseases.
Collapse
Affiliation(s)
- S Georgin-Lavialle
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - V Hentgen
- Service de pédiatrie générale, (CEREMAIA), centre hospitalier de Versailles, 179, rue de Versailles, 78150 Le Chesnay, France
| | - K Stankovic Stojanovic
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - C Bachmeyer
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - F Rodrigues
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - L Savey
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - S Abbara
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - P-L Conan
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - T Fraisse
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - M Delplanque
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - A Rouet
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - N Sbeih
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - I Koné-Paut
- Service de rhumatologie pédiatrique, (CEREMAIA), université de Paris Sud, CHU de Bicêtre, Assistance publique-Hôpitaux de Paris, 94270 Le Kremlin-Bicêtre, France
| | - G Grateau
- Service de médecine interne, centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, hôpital Trousseau, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France; Université Paris 6, Pierre-et-Marie-Curie (UPMC), Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France.
| |
Collapse
|
28
|
Georgin-Lavialle S, Rodrigues F, Hentgen V, Fayand A, Quartier P, Bader-Meunier B, Bachmeyer C, Savey L, Louvrier C, Sarrabay G, Melki I, Belot A, Koné-Paut I, Grateau G. [Clinical overview of auto-inflammatory diseases]. Rev Med Interne 2018; 39:214-232. [PMID: 29501512 DOI: 10.1016/j.revmed.2018.01.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Revised: 12/28/2017] [Accepted: 01/28/2018] [Indexed: 12/12/2022]
Abstract
Monogenic auto-inflammatory diseases are characterized by genetic abnormalities coding for proteins involved in innate immunity. They were initially described in mirror with auto-immune diseases because of the absence of circulating autoantibodies. Their main feature is the presence of peripheral blood inflammation in crisis without infection. The best-known auto-inflammatory diseases are mediated by interleukines that consisted in the 4 following diseases familial Mediterranean fever, cryopyrinopathies, TNFRSF1A-related intermittent fever, and mevalonate kinase deficiency. Since 10 years, many other diseases have been discovered, especially thanks to the progress in genetics. In this review, we propose the actual panorama of the main known auto-inflammatory diseases. Some of them are recurrent fevers with crisis and remission; some others evaluate more chronically; some are associated with immunodeficiency. From a physiopathological point of view, we can separate diseases mediated by interleukine-1 and diseases mediated by interferon. Then some polygenic inflammatory diseases will be shortly described: Still disease, Schnitzler syndrome, aseptic abscesses syndrome. The diagnosis of auto-inflammatory disease is largely based on anamnesis, the presence of peripheral inflammation during attacks and genetic analysis, which are more and more performant.
Collapse
Affiliation(s)
- S Georgin-Lavialle
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, université Pierre-et-Marie-Curie (UPMC)-Paris 6, hôpital Trousseau, Assistance publique-Hôpitaux de Paris, 75012 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France.
| | - F Rodrigues
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France
| | - V Hentgen
- Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France; Service de pédiatrie générale, centre hospitalier de Versailles, 179, rue de Versailles, 78150 Le Chesnay, France
| | - A Fayand
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France
| | - P Quartier
- Unité d'immunologie-hématologie et rhumatologie pédiatriques et institut IMAGINE, université Paris-Descartes, hôpital Necker-Enfants-Malades, Assistance publique-Hôpitaux de Paris, 149, rue de Sèvres, 75743 Paris cedex 15, France; Centre de référence national maladies rares pour les rhumatismes inflammatoires et les maladies auto-immunes systémiques de l'enfant (RAISE), 75015 Paris, France
| | - B Bader-Meunier
- Unité d'immunologie-hématologie et rhumatologie pédiatriques et institut IMAGINE, université Paris-Descartes, hôpital Necker-Enfants-Malades, Assistance publique-Hôpitaux de Paris, 149, rue de Sèvres, 75743 Paris cedex 15, France; Centre de référence national maladies rares pour les rhumatismes inflammatoires et les maladies auto-immunes systémiques de l'enfant (RAISE), 75015 Paris, France
| | - C Bachmeyer
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France
| | - L Savey
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France
| | - C Louvrier
- Inserm UMRS_933, université Pierre-et-Marie-Curie (UPMC)-Paris 6, hôpital Trousseau, Assistance publique-Hôpitaux de Paris, 75012 Paris, France
| | - G Sarrabay
- Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France; Laboratoire de génétique, CHU de Montpellier, 191, avenue du Doyen-Gaston-Giraud, 34090 Montpellier, France
| | - I Melki
- Unité d'immunologie-hématologie et rhumatologie pédiatriques et institut IMAGINE, université Paris-Descartes, hôpital Necker-Enfants-Malades, Assistance publique-Hôpitaux de Paris, 149, rue de Sèvres, 75743 Paris cedex 15, France; Centre de référence national maladies rares pour les rhumatismes inflammatoires et les maladies auto-immunes systémiques de l'enfant (RAISE), 75015 Paris, France; Service de pédiatrie générale, maladies infectieuses et médecine interne pédiatrique, centre hospitalier Robert-Debré, 75020 Paris, France
| | - A Belot
- Centre de référence national maladies rares pour les rhumatismes inflammatoires et les maladies auto-immunes systémiques de l'enfant (RAISE), 75015 Paris, France; Inserm U1111, service de néphrologie, rhumatologie, dermatologie pédiatriques, université Lyon 1, hôpital Femme-Mère-Enfant, 69677 Bron, France
| | - I Koné-Paut
- Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France; Service de rhumatologie pédiatrique, université de Paris-Sud, CHU de Bicêtre, Assistance publique-Hôpitaux de Paris, 94270 Paris, France
| | - G Grateau
- Service de médecine interne, université Paris 6, Pierre-et-Marie-Curie (UPMC), hôpital Tenon, Assistance publique-Hôpitaux de Paris (AP-HP), 20, rue de la Chine, 75020 Paris, France; Inserm UMRS_933, université Pierre-et-Marie-Curie (UPMC)-Paris 6, hôpital Trousseau, Assistance publique-Hôpitaux de Paris, 75012 Paris, France; Centre de référence des maladies auto-inflammatoires et de l'amylose inflammatoire (CEREMAIA), 75020 Paris, France
| |
Collapse
|
29
|
Fayand A, Sarrabay G, Belot A, Hentgen V, Kone-Paut I, Grateau G, Melki I, Georgin-Lavialle S. [Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature]. Rev Med Interne 2017; 39:297-306. [PMID: 29273180 DOI: 10.1016/j.revmed.2017.11.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Accepted: 11/25/2017] [Indexed: 01/15/2023]
Abstract
Deficiency of adenosine deaminase 2 (DADA2) is a recently described auto-inflammatory disorder. It is an autosomal recessive inherited disease, caused by mutations in the ADA2 gene (formerly known as CECR1) encoding ADA2 enzyme. Besides its role in the purine metabolism, it has been postulated that ADA2 may act as a growth factor for endothelial cells and in the differenciation of monocytes. Thus, deficiency of ADA2 would lead to endothelial damage and a skewing of monocytes into M1 pro-inflammatory macrophage, causing DADA2 manifestations. Three core clinical features have been described: inflammatory-vascular signs, hematologic abnormalities and immunodeficiency. Clinically, patients display intermittent fever, cutaneous vascular manifestations, such as livedo, ischemic strokes, arthralgia and abdominal pain crisis. Corticosteroids and immunosuppressive agents (i.e. cyclophosphamide, azathioprine, ciclosporin, methotrexate) appear to be poorly effective. Although the mechanism has not been elucidated, anti-TNF agents have been proven efficient in DADA2 and should therefore be used as first line therapy for vasculitis. Role of anti-platelet and anticoagulant therapies in stroke-prophylaxis remains to be discussed, as those patients display a high risk of intracranial bleeding.
Collapse
Affiliation(s)
- A Fayand
- Department de médecine interne, DHUI2B, département hospitalo-universitaire inflammation, immunopathologie, biothérapie, hôpital Tenon, université Paris 6, Pierre et Marie Curie, Assistance publique-hôpitaux de Paris (AP-HP), 4 rue de la Chine, 75020 Paris, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France
| | - G Sarrabay
- Laboratoire de génétique, CHU de Montpellier, 34090 Montpellier, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France
| | - A Belot
- Inserm U1111, service de rhumatologie pédiatrique, hôpital Femme-Mère-Enfant, université Lyon 1, 69677 Bron, France; Centre de référence des rhumatismes et auto-immunité systémique de l'enfant (RAISE), 75015 Paris, France
| | - V Hentgen
- Service de pédiatrie générale, centre hospitalier de Versailles, 78150 Versailles, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France
| | - I Kone-Paut
- Service de rhumatologie pédiatrique, CHU de Bicêtre, université de Paris Sud, AP-HP, 94270 Kremlin-Bicêtre, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France
| | - G Grateau
- Department de médecine interne, DHUI2B, département hospitalo-universitaire inflammation, immunopathologie, biothérapie, hôpital Tenon, université Paris 6, Pierre et Marie Curie, Assistance publique-hôpitaux de Paris (AP-HP), 4 rue de la Chine, 75020 Paris, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France
| | - I Melki
- Service de pédiatrie générale, maladies infectieuses et médecine interne pédiatrique, centre hospitalier Robert-Debré, 75019 Paris, France; Centre de référence des rhumatismes et auto-immunité systémique de l'enfant (RAISE), 75015 Paris, France
| | - S Georgin-Lavialle
- Department de médecine interne, DHUI2B, département hospitalo-universitaire inflammation, immunopathologie, biothérapie, hôpital Tenon, université Paris 6, Pierre et Marie Curie, Assistance publique-hôpitaux de Paris (AP-HP), 4 rue de la Chine, 75020 Paris, France; Centre de référence des maladies auto-inflammatoires rares et de l'amylose inflammatoire (CEREMAIA), CHU de Tenon, 75020 Paris, France.
| |
Collapse
|
30
|
Delplanque M, Grateau G, Fautrel B, Pouchot J, Gobert P, Taarit BB, Dougados M, Buob D, Georgin Lavialle S. Amylose AA secondaire à une maladie de Still de l’adulte : à propos de 17 cas dont 14 de la littérature et 3 français. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Borocco C, Kone-Paut I, Grateau G, Ulinski T, Belot A, Desjonquères M, Miceli C, Karras A, Moulin B, Boffa J, Buob D, Georgin Lavialle S. Néphropathies non amyloïdes dans les maladies auto-inflammatoires : à propos de 20 cas français. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Bodez D, Guendouz S, Grateau G, Galat A, Avellino V, Kharoubi M, Guellich A, Urbanski G, Itti E, Deux J, Damy T, Georgin Lavialle S. Atteinte cardiaque au cours de l’amylose AA : étude prospective sur 38 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Fayand A, Sarrabay G, Belot A, Hentgen V, Kone-Paut I, Grateau G, Georgin Lavialle S. Le déficit en ADA2, à la frontière entre vasculopathie, maladie auto-inflammatoire et immunodépression : revue de littérature de 93 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Sbeih N, Hoyeau-Idrissi N, Fraisse T, Launay J, Hentgen V, Hermine O, Canioni D, Amselem S, Giurgea I, Louvrier C, Grateau G, Georgin Lavialle S. Implication des mastocytes dans la fièvre méditerranéenne familiale : une étude prospective sur 50 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Stankovic K, Georgin Lavialle S, Buob D, Poitou-Bernert C, Salle V, Urbanski G, Guichard J, Grosbois B, Christides C, Amselem S, Grateau G. L’obésité est-elle une cause émergente d’amylose AA ? À propos d’une cohorte française de 12 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
36
|
Deshayes S, Georgin-Lavialle S, Hot A, Durel C, Hachulla E, Rouanes N, Audia S, Le Gallou T, Urbanski G, Bienvenu B, Aouba A, Grateau G. Traitement continu par anti-interleukine–1 dans le déficit en mévalonate kinase : étude rétrospective multicentrique française de 13 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
Delaleu J, Grateau G, Hentgen V, Aouba A, Giurgea I, Amselem S, Louvrier C, Sene D, Georgin-Lavialle S. Efficacité des anti-Il1 dans le TRAPS : expérience du centre de référence et revue de la littérature. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
38
|
Verney J, Germain N, Meugnier E, Grateau G, Édouard P, Féasson L, Denis C, Ravelojaona M, Vidal H, Estour B, Galusca B. Maigreur constitutionnelle : un phénotype musculaire spécifique. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2017.06.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
39
|
Kone-Paut I, Quartier P, Fain O, Grateau G, Pillet P, Le Blay P, Bonnet F, Despert V, Stankovic-Stojanovic K, Willemin L, Quéré S, Reigneau O, Hachulla E. Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study. Arthritis Care Res (Hoboken) 2017; 69:903-911. [PMID: 27635935 DOI: 10.1002/acr.23083] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Revised: 07/04/2016] [Accepted: 09/06/2016] [Indexed: 11/09/2022]
Abstract
OBJECTIVE The ENVOL study was designed to assess the psychosocial impact of disease and therapy in a French cohort of cryopyrin-associated periodic syndromes (CAPS) patients (and caregivers) treated with canakinumab. METHODS The ENVOL study was a multicenter, observational study of CAPS patients given ≥1 canakinumab dose. Data were collected before treatment, at 6 and 12 months afterward, and at the last visit. Patients and caregivers completed questionnaires assessing changes from the 12 months of pretreatment to 12 months prior to interview. Data were analyzed retrospectively. RESULTS The study included 10 physicians and 68 patients (53 adults, 15 children). Sixty-five patients (95.6%) were still receiving canakinumab at the last visit (median 5 years after starting therapy). The mean ± SD score for patient-reported general health increased from 7 ± 2.9 before canakinumab to 2.7 ± 2.7 after treatment (P < 0.001). Physical and emotional symptoms resolved or improved in a substantial proportion of patients, including bodily pain (38 of 46 patients), fever (32 of 39), skin disease (35 of 41), fatigue (31 of 47), self-confidence (29 of 46), and energy (34 of 47). Social activity, relationships, sexuality, and energy measures improved in >40% of respondents. Caregivers spent a median of 3 versus 0.5 hours/week on care in the 12 months of pretreatment versus 12 months prior to interview (P < 0.001). Following treatment, patients required fewer consultations with general practitioners (mean ± SD per patient per year: 5.2 ± 7.4 versus 8.5 ± 7.2 pretreatment), internists/rheumatologists/dermatologists (2.0 ± 2.1 versus 3.7 ± 3.9), and pediatricians (1.8 ± 1.5 versus 4.4 ± 4.2). CONCLUSION Long-term treatment with canakinumab achieves a highly relevant improvement in the physical, emotional, and social lives of patients with CAPS, accompanied by a marked reduction in support required from caregivers and in health care consultations.
Collapse
Affiliation(s)
- I Kone-Paut
- CEREMAI, Hôpital Bicêtre, APHP, University of Paris Sud, Saclay, Le Kremlin Bicêtre, France
| | - P Quartier
- Université Paris-Descartes-Sorbonne Paris, Institut IMAGINE, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France
| | - O Fain
- Hôpital Saint Antoine, Paris, France
| | - G Grateau
- Hôpital Tenon, DHU I2B, Paris, France
| | - P Pillet
- Hôpital Pellegrin, Bordeaux, France
| | - P Le Blay
- Clinique Hôpital Lapeyronie, Montpellier, France
| | - F Bonnet
- Hôpital Saint André, Bordeaux, France
| | | | | | - L Willemin
- Novartis Pharma SAS, Rueil-Malmaison, France
| | - S Quéré
- Novartis Pharma SAS, Rueil-Malmaison, France
| | - O Reigneau
- Novartis Pharma SAS, Rueil-Malmaison, France
| | - E Hachulla
- Hôpital Huriez, CHRU de Lille, FHU IMMINeNT, Université de Lille, France
| |
Collapse
|
40
|
Bendavid G, Grateau G, Stankovic K, Avellino V, Hentgen V, Georgin-Lavialle S. Connaissance et prise en charge de la fièvre méditerranéenne familiale en ville : enquête auprès de 32 médecins généralistes. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Conan P, Georgin-Lavialle S, Stankovic K, Louvrier C, Giurgea I, Amselem S, Grateau G. Le syndrome d’hyperémèse cannabinoïde : un diagnostic différentiel de la fièvre méditerranéenne familiale : à propos de 7 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
42
|
Fayand A, Kahn J, Boffa J, Cez A, Buob D, Grateau G, Georgin-Lavialle S. La maladie de Castleman, une cause rare d’amylose AA : à propos de 53 cas séronégatifs, incluant la revue de la littérature et 2 cas français. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
43
|
Gusdorf L, Asli B, Barbarot S, Néel A, Masseau A, Puéchal X, Gottenberg JE, Grateau G, Blanchard-Delaunay C, Rizzi R, Lifermann F, Kyndt X, Aubin F, Bessis D, Boye T, Gayet S, Rongioletti F, Sauleau E, Fermand JP, Lipsker D. Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients. Allergy 2017; 72:177-182. [PMID: 27564982 DOI: 10.1111/all.13035] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/24/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical, histological, and biological signs of neutrophil-mediated inflammation. The aim of this study was to assess the applicability and validity of the existing diagnostic criteria in real-life patients. METHODS This multicentric study was conducted between 2009 and 2014 in 14 hospitals in which patients with Schnitzler syndrome or controls with related disorders were followed up. We compared the sensitivities and specificities and calculated the positive and negative predictive values of the Lipsker and of the Strasbourg criteria for the patients with Schnitzler syndrome and for the controls. We included 42 patients with Schnitzler syndrome, 12 with adult-onset Still's disease, 7 with cryopyrin-associated periodic disease, 9 with Waldenström disease, and 10 with chronic spontaneous urticaria. RESULTS All patients with Schnitzler syndrome met the Lipsker criteria. According to the Strasbourg criteria, 34 patients had definite Schnitzler syndrome, five had probable Schnitzler syndrome, and three did not meet the criteria. One control met the Lipsker criteria and had probable Schnitzler syndrome according to the Strasbourg criteria. Sensitivity and specificity of the Lipsker criteria were 100% and 97%, respectively. For the Strasbourg criteria, sensitivity for definite and probable diagnosis was 81% and 93%, respectively, with a corresponding specificity of 100% and 97%. CONCLUSION Diagnostic criteria currently in use to diagnose Schnitzler syndrome are reliable. More investigations must be done to attest their efficiency in patients with recent-onset manifestations.
Collapse
Affiliation(s)
- L. Gusdorf
- Clinique Dermatologique; Hôpitaux Universitaires de Strasbourg; Strasbourg France
| | - B. Asli
- Unité d'Immuno-Hématologie; Hôpital Saint-Louis; Assistance Publique-Hôpitaux de Paris; Paris France
| | - S. Barbarot
- Service de Dermatologie; CHU Hôtel-Dieu; Nantes France
| | - A. Néel
- Service de Médecine Interne; CHU Hôtel Dieu; Nantes France
| | - A. Masseau
- Service de Médecine Interne; CHU Hôtel Dieu; Nantes France
| | - X. Puéchal
- Service de Médecine Interne; Hôpital Cochin; Assistance Publique-Hôpitaux de Paris; Paris France
| | - J-E. Gottenberg
- Service de Rhumatologie; Hôpitaux Universitaires de Strasbourg; Strasbourg France
| | - G. Grateau
- Service de Médecine Interne; Hôpital Tenon; Assistance Publique-Hôpitaux de Paris; Paris France
| | | | - R. Rizzi
- Department of Emergency and Organ Transplantation; Section of Hematology with Transplantation; University of Bari; Bari Italy
| | - F. Lifermann
- Service de Médecine Interne; Centre Hospitalier; Dax France
| | - X. Kyndt
- Service de Médecine Interne; Centre Hospitalier; Valenciennes France
| | - F. Aubin
- Service de Dermatologie; CHU de Besançon; Besançon France
| | - D. Bessis
- Service de Dermatologie; CHU Saint-Eloi; Montpellier France
| | - T. Boye
- Service de Dermatologie; Hôpital d'Instruction des Armées Sainte-Anne; Toulon France
| | - S. Gayet
- Service de Médecine Interne; Gériatrie et Thérapeutique; CHU de la Timone; Marseille France
| | - F. Rongioletti
- Department of Dermatology; University of Genova; Genova Italy
| | - E. Sauleau
- Service de Santé Publique; Hôpitaux Universitaires de Strasbourg; Strasbourg France
| | - J-P. Fermand
- Unité d'Immuno-Hématologie; Hôpital Saint-Louis; Assistance Publique-Hôpitaux de Paris; Paris France
| | - D. Lipsker
- Clinique Dermatologique; Hôpitaux Universitaires de Strasbourg; Strasbourg France
| |
Collapse
|
44
|
Corsia A, Georgin-Lavialle S, Hentgen V, Hachulla E, Grateau G, Faye A, Schleinitz N, Jamilloux Y, Hayem G, Quartier P, Rossi-Semerano L, Kone-Paut I. Enquête sur la résistance à la colchicine dans la fièvre méditerranéenne familiale en France : à propos de 46 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Fayand A, Kone-Paut I, Hentgen V, Stankovic K, Adoue D, Perlat A, Quartier P, Bader-Meunier B, Dhôte R, Amselem S, Grateau G, Georgin-Lavialle S. Le syndrome PFAPA (ou syndrome de Marshall) existe-t-il chez les adultes ? À propos de 20 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
46
|
Rodrigues F, Hentgen V, Louvrier C, Sarrabay G, Stankovic K, Kone-Paut I, Touitou I, Amselem S, Grateau G, Georgin-Lavialle S. Les fièvres héréditaires périodiques associées à des mutations de NLRP12 : revue systématique de la littérature. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Georgin-Lavialle S, Stankovic K, Cez A, Hachulla E, Mekinian A, Le Gallou T, Ziza J, Masseau A, Amselem S, Boffa J, Buob D, Grateau G. Amylose AA secondaire à la fièvre méditerranéenne familiale : à propos de 38 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
48
|
Fraisse T, Bastard J, Fellahi S, Steichen O, Stankovic K, Avellino V, Hentgen V, Faintuch J, Amselem S, Grateau G, Georgin-Lavialle S. Cytolyse au cours de la fièvre méditerranéenne familiale : étude prospective chez 19 adultes. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Georgin-Lavialle S, Galeotti C, Philit JB, Degachi A, Galmiche S, Stankovic K, Hentgen V, Kone-Paut I, Buob D, Grateau G. Amylose AA au cours du déficit en mévalonate kinase : à propos de 14 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
50
|
Galmiche S, Georgin-Lavialle S, Lionnet F, M’bappe P, Stankovic K, Mattioni S, Girot R, Grateau G, Arlet J, Bachmeyer C. Maladies auto-immunes au cours des syndromes drépanocytaires majeurs : étude de 26 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|